-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
CollPlant Biotechnologies Ltd quarterly and annual Revenues history and change rate from 2018 to Q2 2025.
- CollPlant Biotechnologies Ltd Revenues for the quarter ending 30 Jun 2025 was $179,000, a 28.1% decline year-over-year.
- CollPlant Biotechnologies Ltd annual Revenues for 2024 was $515,000, a 95.3% decline from 2023.
- CollPlant Biotechnologies Ltd annual Revenues for 2023 was $10,959,000, a 3565% increase from 2022.
- CollPlant Biotechnologies Ltd annual Revenues for 2022 was $299,000, a 98.1% decline from 2021.
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)